Literature DB >> 28348788

Streptococcus suis serotype 2 strains isolated in Argentina (South America) are different from those recovered in North America and present a higher risk for humans.

Raquel Callejo1, Han Zheng2, Pengcheng Du3, Monica Prieto1, Jianguo Xu2, Gustavo Zielinski4, Jean-Philippe Auger5, Marcelo Gottschalk5.   

Abstract

INTRODUCTION: Streptococcus suis serotype 2 is an important swine pathogen and emerging zoonotic agent causing meningitis and septicemia/septic shock. Strains are usually virulent (Eurasia) or of intermediate/low virulence (North America). Very few data regarding human and swine isolates from South America are available. CASE
PRESENTATION: Seventeen new human S. suis cases in Argentina (16 serotype 2 strains and a serotype 5 strain) are reported. Alongside, 14 isolates from pigs are analyzed: 12 from systemic disease, one from lungs and one from tonsils of a healthy animal. All human serotype 2 strains and most swine isolates are sequence type (ST) 1, as determined by multilocus sequence typing and present a mrp+/epf+/sly+ genotype typical of virulent Eurasian ST1 strains. The remaining two strains (recovered from swine lungs and tonsils) are ST28 and possess a mrp+/epf - /sly- genotype typical of low virulence North American strains. Representative human ST1 strains as well as one swine ST28 strain were analyzed by whole-genome sequencing and compared with genomes from GenBank. ST1 strains clustered together with three strains from Vietnam and this cluster is close to another one composed of 11 strains from the United Kingdom.
CONCLUSION: Close contact with pigs/pork products, a good surveillance system, and the presence of potentially virulent Eurasian-like serotype 2 strains in Argentina may be an important factor contributing to the higher number of human cases observed. In fact, Argentina is now fifth among Western countries regarding the number of reported human cases after the Netherlands, France, the UK and Poland.

Entities:  

Keywords:  Streptococcus suis serotype 2; multilocus sequence typing; sequencing; swine; virulence factors; zoonosis

Year:  2016        PMID: 28348788      PMCID: PMC5343146          DOI: 10.1099/jmmcr.0.005066

Source DB:  PubMed          Journal:  JMM Case Rep        ISSN: 2053-3721


Introduction

Streptococcus suis is an important swine pathogen mainly causing septicemia, meningitis and arthritis (Gottschalk, 2012). In addition, it is an emerging zoonotic agent responsible for septicemia with or without septic shock and meningitis (Gottschalk, 2012). During the last decade, the number of human cases due to S. suis has increased, and while most sporadic human cases of infection occur following close occupational contact with pigs/pork products, particularly in Western countries, important outbreaks have been recorded in Asia. In the latter, the general population is at risk due to consumption of raw pork products as part of traditional dishes. Indeed, S. suis infections are considered to be among the most frequent causes of adult meningitis in Asia (Wertheim ). Although different serotypes have been described, serotype 2 is the most commonly isolated from diseased pigs; it also represents more than 95 % of human cases worldwide (Goyette-Desjardins ). However, important differences in virulence of isolates within this serotype have been described (Auger ). It has been shown that Eurasian strains generally present a higher virulence potential than those from Canada and the USA, two countries that together are the second most important swine producers worldwide after China (Gottschalk, 2012). Multilocus sequence typing (MLST) has been used worldwide to determine the sequence types (STs) of S. suis strains, thus allowing the gathering of further information regarding their genetic diversity and evolution (Goyette-Desjardins ). More recently, studies have begun combining data obtained from MLST with the presence or absence of different S. suis serotype 2 virulence-associated markers such as muramidase released protein (mrp), extracellular protein factor (epf), and suilysin (sly), to compare ST data with pathotypes. ST1 strains, which are usually more virulent and possess a genotypic mrppathotype profile, are mostly present in Eurasia, whereas ST25 (intermediate virulence) and ST28 (low virulence) strains with a mrp profile predominate in North America (Goyette-Desjardins ; Lopreto ). Interestingly, human cases reported in North America represent less than 0.5 % of described cases worldwide, compared with more than 8 % in European countries, confirming differences in virulence of S. suis serotype 2 isolates (Goyette-Desjardins ; Auger ). Very few data are available concerning serotype 2 strains recovered from diseased pigs in South America (Doto ; Martinez), where the swine industry is either well-developed (such as in Brazil) or in clear expansion (such as in Argentina). Herein, we describe new human cases of S. suis recovered from diseased patients in Argentina. We have also studied strains isolated from diseased pigs in this country. MLST and pathotype characteristics of strains were determined and representative strains recovered from humans were further analyzed by whole-genome sequencing (WGS).

Case Report

We present the characteristics of 32 S. suis strains isolated in Argentina (Table 1). We report and analyze 17 human cases of S. suis in Argentina isolated between 1995 and 2016. An additional strain from a previously reported human patient (Lopreto ) was also included. All but one of the human strains were isolated from cases of meningitis; the remaining strain was recovered from a patient presenting septic arthritis. Of the 17 cases of meningitis, 7 strains were isolated exclusively from the cerebrospinal fluid (CSF), while the remaining strains were isolated from both CSF and blood. In the latter cases, only one isolate per patient was further characterized. Three isolates were recovered from female patients and 13 patients, from rural areas, recalled having had contact with swine, pork or pork-derived products. Four patients did not recall this information, whereas one patient assured us of having had no such contact.
Table 1.

S. suis strains isolated from humans or pigs in Argentina included in this study

StrainSource*ClinicalmanifestationSerotypeHostDateGenderSwine/pork contactPathotypeST
285†CSF, bloodMeningitis2H1995MYesmrp+/epf+/sly+1
284CSF, bloodMeningitis2H1995MYesmrp+/epf+/sly+1
263†CSF, bloodMeningitis2H2003MYesmrp+/epf+/sly+1
178†CSF, bloodMeningitis2H2003MYesmrp+/epf+/sly+1
247†CSF, bloodMeningitis2H2003MYesmrp+/epf+/sly+1
2376‡CSFMeningitis2H2004FYesmrp+/epf+/sly+1
12†CSF, bloodMeningitis2H2009MYesmrp+/epf+/sly+1
83CSF, bloodMeningitis2H2009MUnknownmrp+/epf+/sly+1
88CSFMeningitis2H2009MYesmrp+/epf+/sly+1
245†CSFMeningitis2H2012MYesmrp+/epf+/sly+1
486†CSF, bloodMeningitis2H2012MUnknownmrp+/epf+/sly+1
371†CSF, bloodMeningitis2H2013MYesmrp+/epf+/sly+1
473†CSFMeningitis2H2013FUnknownmrp+/epf+/sly+1
42CSF, bloodMeningitis2H2014FUnknownmrp+/epf+/sly+1
130/15CSFMeningitis2H2015MYesmrp+/epf+/sly+1
695-15CSFMeningitis2H2015MYesmrp+/epf+/sly+1
136-16JointArthritis2H2016MNomrp+/epf+/sly+1
15§CSFMeningitis5H2014MYesndnd
P156SpleenSepticemia2S2000nanamrp+/epf+/sly+1
P232JointArthritis2S2001nanamrp+/epf+/sly+1
050798BrainMeningitis2S2001nanamrp+/epf+/sly+1
P421JointArthritis2S2002nanamrp+/epf+/sly+1
130387BrainMeningitis2S2002nanamrp+/epf+/sly+1
P517BrainMeningitis2S2003nanamrp+/epf+/sly+1
477HeartEndocarditis2S2003nanamrp+/epf+/sly+1
P613BrainMeningitis2S2005nanamrp+/epf+/sly+1
P655HeartEndocarditis2S2005nanamrp+/epf+/sly+1
P574JointArthritis2S2005nanamrp+/epf+/sly+1
P611BrainMeningitis2S2005nanamrp+/epf+/sly+1
P706†LungsPneumonia2S2006nanamrp+/epf/sly28
50703-8BrainMeningitis2S2010nanamrp+/epf/sly1
BE 21¶TonsilsNone2S2014nanamrp+/epf/sly28

*When two sources of isolates are mentioned for the same patient, only one strain was characterized; †Strains studied by whole-genome sequencing (see Table 2); ‡(Lopreto ); §Fatal case; ¶Clinically healthy pig. ST, sequence type (as evaluated by multilocus sequence typing); CSF, cerebrospinal fluid; nd, not determined; na, not applicable.

*When two sources of isolates are mentioned for the same patient, only one strain was characterized; †Strains studied by whole-genome sequencing (see Table 2); ‡(Lopreto ); §Fatal case; ¶Clinically healthy pig. ST, sequence type (as evaluated by multilocus sequence typing); CSF, cerebrospinal fluid; nd, not determined; na, not applicable.
Table 2.

List of strains used for comparison of the whole-genome sequencing of S. suis from Argentina (see Table 1)

Strain numberCountrySTYearHostClinical signs
S90CUK12010PigDiseased
S11NUK12010PigDiseased
S98YUK12010PigDiseased
S13BUK12010PigDiseased
S16EUK12010PigDiseased
S15UUK12010PigDiseased
S13FUK12010PigDiseased
P1/7UK11980PigDiseased
S92DUK12010PigDiseased
S17GUK12010PigDiseased
S16DUK12010PigDiseased
S16BUK12010PigDiseased
S12UUK12010PigDiseased
R735Netherlands11963PigMeningitis
YS1China12011PigHealthy
GZ1China12005HumanMeningitis
ZGST1China12015HumanMeningitis
RC1*China3082005PigHealthy
BM237aVietnam12001HumanMeningitis
BM407Vietnam12004HumanMeningitis
BM190aVietnam12000HumanMeningitis
BM264aVietnam12002HumanMeningitis
BM346BVietnam12003HumanMeningitis
BM478Vietnam12014HumanMeningitis
BM224CVietnam12001HumanMeningitis
BM461Vietnam12014HumanMeningitis
BM424aVietnam12004HumanMeningitis

*Serotype 8 (outgroup)

We also studied 14 S. suis serotype 2 strains recovered from pigs, as pure cultures, from non-related farms: 12 were from systemic disease (meningitis, arthritis or endocarditis). In addition, a strain isolated from the lungs of an animal with pneumonia and another strain isolated from the tonsils of a clinically healthy animal were included.

Investigations

Identification of S. suis by PCR and multiplex PCR was performed as previously described (Okura ). Strains positive for serotype 2 were further differentiated from those positive for serotype 1/2 by coagglutination test (Gottschalk ). All but one strain from human cases of infection were serotype 2; the remaining strain (the only fatal case) was characterized as serotype 5. No further characterization of this strain was completed. To evaluate pathotype based on the presence or absence of the traditional virulence factor genes mrp, epf and sly, specific PCRs were performed on serotype 2 strains as previously described (Silva ). Interestingly, all serotype 2 strains isolated from humans present the mrp profile usually associated with virulent Eurasian serotype 2 strains (Goyette-Desjardins ). The epf genotype obtained refers to the variant encoding the 110 kDa protein (Smith ). All but two strains recovered from pigs also presented this pathotype. The two exceptions were the strain isolated from lungs and that recovered from tonsils of a clinically healthy animal, which both presented the mrpprofile usually found in North America. Results from MLST studies, performed as previously described (King ), confirm such results. All strains presenting the mrp pathotype were ST1, similar to most virulent Eurasian strains (Goyette-Desjardins ). The two swine strains presenting the mrp profile (one recovered from lungs and the other from tonsils of a clinically healthy animal) were ST28, which is usually associated with low virulence strains in Canada and the USA (Goyette-Desjardins ). Since almost all Argentinean serotype 2 strains from humans and diseased pigs included in this study were ST1, we further compared nine available human ST1 strains and one porcine ST28 strain by WGS. Phylogenetic analyses were performed and compared with the available assembled GenBank genome sequence read data of 26 ST1 strains from the United Kingdom (13 strains), the Netherlands (one strain, reference strain), PR China (three strains), and Vietnam (nine strains) (Table 2). In addition, a Chinese serotype 8 strain was also included as an outsider control. The sequences of strain P1/7 (UK), GZ1 (PR China), BM407 (Vietnam) and R735 (the Netherlands) are completely finished. The methodology used was that previously described (Chen ). For each strain, a 500 bp library was constructed and then sequenced using the Hiseq 4000 system (Illumina) to produce 150 bp paired-end reads. The high-throughput read data were mapped to the reference genome of S. suis ST1 strain P1/7 (Accession number: NC_012925) using SOAP2 and SNPs detected using SOAPsnp v1.03 (Li ). For the assembled genome sequences, SNPs were called using MUMmer v3.23 (Delcher ). These SNP patterns were distilled and concatenated using an automatic pipeline as previously described (Chen ). Based on this, a phylogenetic tree was reconstructed using the maximum-likelihood method and GTRGAMMA substitution model via raxml software (version 7.2.8) with 1000 bootstrap replications (Stamatakis, 2006). (Fig. 1). The sequencing data were deposited in the GenBank database (Accession number SRP079937).
Fig. 1.

Phylogenetic relationship of ST1 strains. (a) Phylogenetic tree of all strains (including sequence type) used in this study. The ST1 cluster was compressed and is indicated by a triangle. (b) Phylogenetic tree of ST1 strains included in the present study compared with available data from GenBank. The numbers on the branches correspond to the bootstrap values. Strains from different areas are represented by different colors: Asia (black), Europe (blue) and Argentina (red). Geographical origins and year of isolation are included, in parentheses, after the strain name.

*Serotype 8 (outgroup) Phylogenetic relationship of ST1 strains. (a) Phylogenetic tree of all strains (including sequence type) used in this study. The ST1 cluster was compressed and is indicated by a triangle. (b) Phylogenetic tree of ST1 strains included in the present study compared with available data from GenBank. The numbers on the branches correspond to the bootstrap values. Strains from different areas are represented by different colors: Asia (black), Europe (blue) and Argentina (red). Geographical origins and year of isolation are included, in parentheses, after the strain name. Approximately 1.36–1.63 Gb high-quality read data was obtained for each strain and covered 680–858-fold (769±45) of the complete genome of P1/7. A phylogenetic study showed that all of the ST1 strains clustered tightly together when compared with the ST28 strain P706 and ST308 (RC1, PR China) strain (Fig. 1a). Within the ST1 cluster, the nine Argentinean ST1 strains tested clustered together with three other strains from Vietnam, with this cluster being close to another one composed of 11 strains from the UK (Fig. 1b). These two clusters are relatively far away from other European (UK and the Netherlands) and Asian (China and Vietnam) strains.

Discussion

It has been clearly shown that serotype 2 strains isolated in North America (Canada and the USA) are phenotypically and genotypically highly different from those recovered in Europe and Asia (Fittipaldi ). Preliminary results with archetypal strains (Fittipaldi ), as well as more recent results with field strains (Auger ; Athey ), showed that North American S. suis serotype 2 strains are, in general, of low virulence. It has been strongly suggested that the relatively low number of human cases in both Canada and the USA (which together represent the second largest swine producing region worldwide after China) are probably due to the lower virulence properties of S. suis ST25 and ST28 strains that predominate in these countries. Very few data are available regarding strains isolated in South America. A few reports on serotype 2 strains recovered from diseased pigs in Brazil have been published (Costa ; Doto ; Rocha ), though no human case has yet been reported. Human cases have been reported in Argentina (Lopreto ; Callejo ; Nagel ) and, only once, in Chile (Alarcon ), but strains were not further characterized. Although not a traditional pork-producing country, Argentina has significantly increased its swine production in the last few years, having presently more than 4 000 000 pigs (http://www.porcinos.org.ar/). In this study, we analyzed 18 S. suis strains isolated from humans, 17 of which were serotype 2. With the addition of another case for which the strain was not available (Nagel ) and a serotype 21 strain previously described by us (Callejo ), this number is considerably higher than in the important swine producing countries of Canada and the USA. Three different factors may explain these differences: (a) the presence of backyard types of swine production; (b) a good surveillance system in rural hospitals and (c) the presence of potentially virulent strains, when compared with those found in North America. Relatively close contact with pigs/pork products and animals slaughtered at home cannot be ruled out as a possible factor contributing to this atypically high prevalence. More than 75 % of farms in Argentina have fewer than 10 sows (http://www.porcinos.org.ar/), indicating a relatively high number of backyard family types of production with which human S. suis infections have been traditionally associated (Huong ). Most patients described in this study had contact with swine/pork products and/or live in rural areas. However, it is important to note that typical dishes using raw blood or meat (such as are commonly consumed in some Asian countries) do not exist in the Argentinean culture (Gottschalk ). In addition, and since the first human case of S. suis has been described more than 10 years ago (Lopreto ), a good surveillance system for the characterization of alpha-hemolytic bacteria recovered from cases of meningitis in rural hospitals has been established. Each suspicious isolate is immediately sent to the National Institute of Microbiology for further identification. Consequently, close contact with pigs/pork and a good surveillance system may have contributed to the proper identification of these cases. However, in the present study, we also demonstrated that serotype 2 strains recovered from either ill patients or systemically diseased pigs in Argentina are mostly ST1 strains with a typical mrpgenotype that characterizes virulent Eurasian strains. This markedly differs from lower virulence ST25/ST28 North American strains, which have a mrp+/−/epf genotype (Fittipaldi ). WGS results indicated that two strains from the UK (S90C and S11N) are clustered together in lineage 1 and significantly diverged from other strains of lineage 2 (Fig. 1b). These two lineages may have evolved from the ancestor of ST1 before separating, with lineage 2 having become dominant. Within this lineage, most strains could be clustered into three main groups with the exception of the Chinese strain ZGST1. Argentinean strains and three strains from Vietnam were clustered into group 1. Strains from the UK, two Chinese strains, other Vietnamese strains, and the old reference strain from the Netherlands were clustered into groups 2 and 3. A reasonable hypothesis is that the ST1 originated in Europe (UK) where a dominant lineage evolved before spreading to other countries maybe via the introduction of animals from genetic companies. In many countries, including China, Vietnam and Argentina, the advanced breeds of pigs have been introduced from European countries like the UK and Denmark. Interestingly, the strains in these three groups of lineage 2 were all isolated in more than one country from different continents. It would appear that these groups diverged before the spreading and were transmitted, in parallel, to different countries. Interestingly, all strains from diseased pigs in this study were also ST1. Since some genetic breeders from North America have also been incorporated in Argentina, it is possible that North-American-like serotype 2 strains are also present. In fact, one strain isolated from a diseased pig (pneumonia, lungs) and another recovered from tonsils of a clinically healthy pig were typical ST28 strains with a mrp genotype profile identical to that found in Canada and the USA (Fittipaldi ). In this study, the strain isolated from lungs grouped far from all ST1 strains (Fig. 1a). These strains are most probably of low virulence; it has been previously reported that S. suis is not a primary cause of pneumonia and isolates recovered from lungs are often low-virulence (Gottschalk, 2012). It is important to note that these strains are also able to induce serious disease in Canada and the USA. The most important difference between these countries and Argentina, from the disease status point of view, is the absence of the most important swine virus from this South American country: the porcine reproductive and respiratory syndrome virus, which is considered one of the most important predisposing factors for S. suis infection (Gottschalk, 2012). In the absence of this virus, only virulent S. suis strains are usually able to cause important disease in swine. Finally, transmission of ST1 strains from South America to North America is probably low since pig flow from genetic companies and breeders is usually from Europe and North America to South America. Finally, we report the first human case of serotype 5 in Argentina (the only fatal case in the present study). Although this is the first report of this serotype in South America, one case of septic arthritis and one case of peritonitis have been previously described in Sweden and Thailand, respectively (Kerdsin ; Gustavsson ). In addition, one human case of arthroplasty infection with streptococcal toxic shock-like syndrome, was caused by a non-encapsulated strain belonging to this serotype in the USA (Gomez ). In conclusion, and in addition to the probably close contact with pigs/pork products and a good surveillance system, the presence of potentially virulent Eurasian-like serotype 2 strains in Argentina may be an important risk factor contributing to the higher number of human cases observed. In fact, and with this report, Argentina is now among the Western countries with the highest number of reported human cases after the Netherlands, France and the UK, with a similar number of cases to Poland (Bojarska ). However, the three former European countries began the identification of S. suis in humans more than 15 years before Argentina, so the total number of human cases in this South American country may have been underestimated. Further studies in other South American countries, such as Brazil, where swine production is very important, should be performed.
  26 in total

1.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

2.  [Laboratory confirmation of Streptococcus suis in Chile].

Authors:  Pedro Alarcón L; Pamela Araya R; Carolina Aguayo; Jorge Fernández; Vijna Illesca; Angela Zaror; Alejandra Vaquero
Journal:  Rev Chilena Infectol       Date:  2013-10       Impact factor: 0.520

3.  Streptococcus suis-related prosthetic joint infection and streptococcal toxic shock-like syndrome in a pig farmer in the United States.

Authors:  Eric Gomez; Cassie C Kennedy; Marcelo Gottschalk; Scott A Cunningham; Robin Patel; Abinash Virk
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

4.  Genetic diversity of Streptococcus suis serotype 2 isolated from pigs in Brazil.

Authors:  Daniela Sabatini Doto; Luisa Zanolli Moreno; Franco Ferraro Calderaro; Carlos Emilio Cabrera Matajira; Vasco Tulio de Moura Gomes; Thais Sebastiana Porfida Ferreira; Renan Elias Mesquita; Jorge Timenetsky; Marcelo Gottschalk; Andrea Micke Moreno
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

5.  Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange.

Authors:  Samantha J King; James A Leigh; Peter J Heath; Inmaculada Luque; Carmen Tarradas; Christopher G Dowson; Adrian M Whatmore
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

6.  Minimum core genome sequence typing of bacterial pathogens: a unified approach for clinical and public health microbiology.

Authors:  Chen Chen; Wen Zhang; Han Zheng; Ruiting Lan; Haiyin Wang; Pengcheng Du; Xuemei Bai; Shaobo Ji; Qiong Meng; Dong Jin; Kai Liu; Huaiqi Jing; Changyun Ye; George F Gao; Lei Wang; Marcelo Gottschalk; Jianguo Xu
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

7.  Complex Population Structure and Virulence Differences among Serotype 2 Streptococcus suis Strains Belonging to Sequence Type 28.

Authors:  Taryn B T Athey; Jean-Philippe Auger; Sarah Teatero; Audrey Dumesnil; Daisuke Takamatsu; Jessica Wasserscheid; Ken Dewar; Marcelo Gottschalk; Nahuel Fittipaldi
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 8.  Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing.

Authors:  Guillaume Goyette-Desjardins; Jean-Philippe Auger; Jianguo Xu; Mariela Segura; Marcelo Gottschalk
Journal:  Emerg Microbes Infect       Date:  2014-06-18       Impact factor: 7.163

9.  Streptococcus suis in invasive human infections in Poland: clonality and determinants of virulence and antimicrobial resistance.

Authors:  A Bojarska; E Molska; K Janas; A Skoczyńska; E Stefaniuk; W Hryniewicz; E Sadowy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-15       Impact factor: 3.267

10.  Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam.

Authors:  Heiman F L Wertheim; Huyen Nguyen Nguyen; Walter Taylor; Trinh Thi Minh Lien; Hoa Thi Ngo; Thai Quoc Nguyen; Bich Ngoc Thi Nguyen; Ha Hong Nguyen; Ha Minh Nguyen; Cap Trung Nguyen; Trinh Tuyet Dao; Trung Vu Nguyen; Annette Fox; Jeremy Farrar; Constance Schultsz; Hien Duc Nguyen; Kinh Van Nguyen; Peter Horby
Journal:  PLoS One       Date:  2009-06-22       Impact factor: 3.240

View more
  8 in total

1.  Effects of Environmental and Management-Associated Factors on Prevalence and Diversity of Streptococcus suis in Clinically Healthy Pig Herds in China and the United Kingdom.

Authors:  A W Dan Tucker; Rui Zhou; Geng Zou; Jianwei Zhou; Ran Xiao; Liangsheng Zhang; Yuting Cheng; Hui Jin; Lu Li; Lijun Zhang; Bin Wu; Ping Qian; Shaowen Li; Lixin Ren; Jinhong Wang; Olusegun Oshota; Juan Hernandez-Garcia; Thomas M Wileman; Stephen Bentley; Lucy Weinert; Duncan J Maskell
Journal:  Appl Environ Microbiol       Date:  2018-04-02       Impact factor: 4.792

2.  Genotypic diversity of Streptococcus suis strains isolated from humans in Thailand.

Authors:  Anusak Kerdsin; Yukihiro Akeda; Dan Takeuchi; Surang Dejsirilert; Marcelo Gottschalk; Kazunori Oishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-07       Impact factor: 3.267

Review 3.  Streptococcus suis - The "Two Faces" of a Pathobiont in the Porcine Respiratory Tract.

Authors:  Désirée Vötsch; Maren Willenborg; Yenehiwot B Weldearegay; Peter Valentin-Weigand
Journal:  Front Microbiol       Date:  2018-03-15       Impact factor: 5.640

4.  The bacteriocin from the prophylactic candidate Streptococcus suis 90-1330 is widely distributed across S. suis isolates and appears encoded in an integrative and conjugative element.

Authors:  Yukun Sun; Iva A Veseli; Katy Vaillancourt; Michel Frenette; Daniel Grenier; Jean-François Pombert
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

5.  Genomic and pathogenic investigations of Streptococcus suis serotype 7 population derived from a human patient and pigs.

Authors:  Pujun Liang; Mingliu Wang; Marcelo Gottschalk; Ana I Vela; April A Estrada; Jianping Wang; Pengcheng Du; Ming Luo; Han Zheng; Zongfu Wu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

6.  The global emergence of a novel Streptococcus suis clade associated with human infections.

Authors:  Xingxing Dong; Yanjie Chao; Yang Zhou; Rui Zhou; Wei Zhang; Vincent A Fischetti; Xiaohong Wang; Ye Feng; Jinquan Li
Journal:  EMBO Mol Med       Date:  2021-06-17       Impact factor: 12.137

7.  Streptococcus suis serotype 9 endocarditis and subsequent severe meningitis in a growing pig despite specific bactericidal humoral immunity.

Authors:  Karoline Rieckmann; Kristin Müller; Annette Moter; Christoph G Baums; Anna Seydel
Journal:  JMM Case Rep       Date:  2017-05-03

8.  Combination Therapy Strategies Against Multiple-Resistant Streptococcus Suis.

Authors:  Yang Yu; Jin-Tao Fang; Mei Zheng; Qing Zhang; Timothy R Walsh; Xiao-Ping Liao; Jian Sun; Ya-Hong Liu
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.